Clinical Trial Update: A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of topiramate in maintaining weight loss after an intensive, nonpharmacologic weight loss program in obese adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity | Phase 3 | Status: COMPLETED